Transcription factor RUNX2 up-regulates chemokine receptor CXCR4 to promote invasive and metastatic potentials of human gastric cancer
Authors:
Open Access
- 21 March 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (15) , 20999-21012
Abstract
Transcription factor RUNX2 up-regulates chemokine receptor CXCR4 to promote invasive and metastatic potentials of human gastric cancerKeywords
This publication has 50 references indexed in Scilit:
- Whole-genome analysis informs breast cancer response to aromatase inhibitionNature, 2012
- Opposing Effects of Runx2 and Estradiol on Breast Cancer Cell Proliferation: In Vitro Identification of Reciprocally Regulated Gene Signature Related to Clinical Letrozole ResponsivenessClinical Cancer Research, 2012
- Association between RUNX3 promoter methylation and gastric cancer: a meta-analysisBMC Gastroenterology, 2011
- TGF-β-RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone MetastasesCancer Research, 2011
- Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesionsOncogene, 2009
- Ectopic Runx2 Expression in Mammary Epithelial Cells Disrupts Formation of Normal Acini Structure: Implications for Breast Cancer ProgressionCancer Research, 2009
- The evolutionary origin of the Runx/CBFbeta transcription factors – Studies of the most basal metazoansBMC Ecology and Evolution, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysisThe Lancet Oncology, 2008
- Applied bioinformatics for the identification of regulatory elementsNature Reviews Genetics, 2004